ImmuPharma plc (AIM:IMM)
London
· Delayed Price · Currency is GBP · Price in GBX | Market Cap | 14.33M |
| Revenue (ttm) | -69.96K |
| Net Income (ttm) | -2.46M |
| Shares Out | 416.44M |
| EPS (ttm) | -0.01 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 632,246 |
| Average Volume | 3,092,766 |
| Open | 3.650 |
| Previous Close | 3.440 |
| Day's Range | 3.200 - 3.650 |
| 52-Week Range | 0.850 - 7.400 |
| Beta | 2.58 |
| RSI | 45.58 |
| Earnings Date | Apr 24, 2025 |
About ImmuPharma
ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics in the United Kingdom. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company’s lead product candidate is the P140 (Lupuzor), a peptide technology platform, which is in Phase III clinical trial that targets autoimmune diseases for systemic lupus erythematosus; P140 which is in Phase II for chronic inflammatory demyelinating polyneuropathy, a progressive inflammatory condition of ... [Read more]
Financial Performance
Financial StatementsNews
Data show speculative traders have flipped from a net short to a net long position on euro
The IMM CFTC positioning data, released weekly by the Commodity Futures Trading Commission (CFTC), provides insights into how speculative traders, such as hedge funds and large investors, are position...
AIM Market Roundup: Immupharma, Poolbeg, Xeros
ImmuPharma, Poolbeg Pharma, Xeros Technology, RBG Holdings, Coro Energy are today's biggest risers and fallers on London's AIM market
Three Quick Facts: Norman Broadbent, Computacenter, Immupharma
Norman Broadbent, Computacenter, ImmuPharma are Tony Cross's three picks from today's financial market news